[Immunologic abnormalities in the course of myeloid splenomegaly with myelosclerosis].
D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear / Q000032:analysis; D001323:Autoantibodies / Q000032:analysis; D001797:Blood Protein Electrophoresis; D001856:Bone Marrow Examination; D003298:Coombs Test; D003450:Cryoglobulins / Q000032:analysis; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007437:Intrinsic Factor; D008297:Male; D008875:Middle Aged; D008928:Mitochondria; D009196:Myeloproliferative Disorders / Q000150:complications / Q000276:immunology*; D009504:Neutrophils; D010447:Peptide Hydrolases; D055728:Primary Myelofibrosis / Q000209:etiology*; D012217:Rheumatoid Factor / Q000032:analysis; D013163:Splenomegaly / Q000209:etiology*; D013961:Thyroid Gland
D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D003450:Cryoglobulins; D007437:Intrinsic Factor; D012217:Rheumatoid Factor; D010447:Peptide Hydrolases
Anomalies immunitaires au cours de splénomégalies myéloïdes avec myélosclérose